10x Genomics is a life sciences technology company that develops instruments, consumables, and software for analyzing biological systems at single-cell and spatial resolution. Its key platforms include the Chromium system for single-cell analysis, the Visium platform for spatial transcriptomics, and the Xenium platform for in situ analysis. Products serve academic, government, and biopharmaceutical researchers across oncology, immunology, and neuroscience. Since 2015, the company has sold 8,046 instruments across 50+ countries, generating $642.8 million in revenue for 2025.
Q2 FY2026 — expected 2026-08-08
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Blockchain & Crypto | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Regulation | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| metric | TXG gross margin | reported $69 percent | Q4 FY2025 |
| guidance | TXG | guided Guidance 10x Genomics expects full year 2026 revenue to be in the range of $600 million | Q4 FY2025 |
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Semiconductor | Q4 FY2025 |
| topic_mention | TXG | discussed Capital Expenditure | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Sovereign & Government | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| guidance | TXG | guided guidance range, and closed the year with $599 million | Q4 FY2025 |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001628280-26-007822 | EDGAR | 80K words |
| 2025-02-13 | 2024-12-31 | 0001770787-25-000013 | EDGAR | 77K words |
| 2024-02-15 | 2023-12-31 | 0001770787-24-000017 | EDGAR | 88K words |
| 2023-02-16 | 2022-12-31 | 0001770787-23-000012 | EDGAR | — |
| 2022-02-18 | 2021-12-31 | 0001770787-22-000015 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001770787-21-000009 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001193125-20-052640 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001628280-26-054491 | EDGAR | 16K words |
| 2025-11-07 | 2025-09-30 | 0001628280-25-050332 | EDGAR | 16K words |
| 2025-08-08 | 2025-06-30 | 0001770787-25-000051 | EDGAR | 14K words |
| 2025-05-09 | 2025-03-31 | 0001770787-25-000032 | EDGAR | 53K words |
| 2024-10-29 | 2024-09-30 | 0001770787-24-000073 | EDGAR | 16K words |
| 2024-08-08 | 2024-06-30 | 0001770787-24-000060 | EDGAR | 15K words |
| 2024-04-30 | 2024-03-31 | 0001770787-24-000036 | EDGAR | 14K words |
| 2023-11-03 | 2023-09-30 | 0001770787-23-000053 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001770787-23-000047 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001770787-23-000029 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001770787-22-000057 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001770787-22-000049 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001628280-26-054273 | EDGAR | 3K words |
| 2026-02-12 | 0001628280-26-007673 | EDGAR | 3K words |
| 2026-01-12 | 0001628280-26-001808 | EDGAR | 1K words |
| 2025-11-14 | 0001628280-25-052154 | EDGAR | 1K words |
| 2025-11-06 | 0001770787-25-000058 | EDGAR | 3K words |
| 2025-08-07 | 0001770787-25-000048 | EDGAR | 3K words |
| 2025-06-05 | 0001770787-25-000040 | EDGAR | 1K words |
| 2025-05-14 | 0001770787-25-000035 | EDGAR | 1K words |
| 2025-05-08 | 0001770787-25-000031 | EDGAR | 3K words |
| 2025-02-12 | 0001770787-25-000011 | EDGAR | 3K words |
101 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0001770787 |
| Ticker | TXG |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Headquarters | Pleasanton, California |
| Website | https://www.10xgenomics.com |
| Listed | 2019-09-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TXG (~200 tokens, structured JSON with cryptographic provenance)